389 related articles for article (PubMed ID: 18596052)
1. The British Society for Rheumatology Biologics Register: 6 years on.
Hyrich KL; Watson KD; Isenberg DA; Symmons DP;
Rheumatology (Oxford); 2008 Oct; 47(10):1441-3. PubMed ID: 18596052
[No Abstract] [Full Text] [Related]
2. Comparative overview of safety of the biologics in rheumatoid arthritis.
Khraishi M
J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
[TBL] [Abstract][Full Text] [Related]
3. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice.
Sfriso P; Salaffi F; Montecucco CM; Bombardieri S; Todesco S
Reumatismo; 2009; 61(2):132-9. PubMed ID: 19633800
[TBL] [Abstract][Full Text] [Related]
4. Joint approach.
Palmer K
Minn Med; 2009 Sep; 92(9):22-5. PubMed ID: 19877473
[No Abstract] [Full Text] [Related]
5. Risk of Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis treated with inhibitors of tumour necrosis factor α: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Bruce ES; Kearsley-Fleet L; Watson KD; Symmons DP; Hyrich KL
Rheumatology (Oxford); 2016 Jul; 55(7):1336-7. PubMed ID: 27118877
[No Abstract] [Full Text] [Related]
6. [Recommendations of the German Society of Rheumatology for therapy with tumor necrosis factor inhibitors. Pharmacotherapy Committee of the German Society of Rheumatology].
Z Rheumatol; 2000 Aug; 59(4):291-2. PubMed ID: 11013988
[No Abstract] [Full Text] [Related]
7. Comment on: Modelling the cost effectiveness of TNF antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry.
van Vollenhoven RF;
Rheumatology (Oxford); 2008 Jul; 47(7):1106-7; author reply 1107. PubMed ID: 18326533
[No Abstract] [Full Text] [Related]
8. Use of biologic agents in rheumatoid arthritis: introduction.
Silman AJ
Rheumatology (Oxford); 2011 Sep; 50 Suppl 4():iv3-4. PubMed ID: 21859703
[No Abstract] [Full Text] [Related]
9. BSR Biologics Registry.
Griffiths I; Silman A; Symmons D; Scott DG
Rheumatology (Oxford); 2004 Dec; 43(12):1463-4. PubMed ID: 15328420
[No Abstract] [Full Text] [Related]
10. [Safety of biologic therapy - results from the German biologics register RABBIT].
Strangfeld A; Zink A
Dtsch Med Wochenschr; 2014 Sep; 139(37):1817-20. PubMed ID: 25180996
[No Abstract] [Full Text] [Related]
11. British Society for Rheumatology Biologics Register.
Silman A; Symmons D; Scott DG; Griffiths I
Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii28-9. PubMed ID: 14532144
[TBL] [Abstract][Full Text] [Related]
12. Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register.
Dixon WG; Watson KD; Lunt M; Mercer LK; Hyrich KL; Symmons DP; ;
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):755-63. PubMed ID: 20535785
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis.
Lorenzo M
Foot Ankle Clin; 2007 Sep; 12(3):525-37, vii. PubMed ID: 17765843
[TBL] [Abstract][Full Text] [Related]
14. [Rheumatoid arthritis: early aggressive therapy including biologicals -- pro].
Rubbert-Roth A
Dtsch Med Wochenschr; 2005 Aug; 130(33):1900. PubMed ID: 16118736
[No Abstract] [Full Text] [Related]
15. [Focusing on the use of biologics in rheumatoid arthritis].
Devauchelle-Pensec V; Guellec D
Rev Prat; 2015 May; 65(5):687-8. PubMed ID: 26165113
[No Abstract] [Full Text] [Related]
16. Are we coming to terms with tumor necrosis factor inhibition in pregnancy?
Salmon JE; Alpert D
Arthritis Rheum; 2006 Aug; 54(8):2353-5. PubMed ID: 16868990
[No Abstract] [Full Text] [Related]
17. 'Treat to target' for rheumatoid arthritis in 2014--time tested triple therapy or logical biologics?
Mok MY; Danda D
Int J Rheum Dis; 2014 Jan; 17(1):1-3. PubMed ID: 24472259
[No Abstract] [Full Text] [Related]
18. The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road.
Bathon JM; Cohen SB
Arthritis Rheum; 2008 Jun; 59(6):757-9. PubMed ID: 18512712
[No Abstract] [Full Text] [Related]
19. Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again).
Deighton CM; George E; Kiely PD; Ledingham J; Luqmani RA; Scott DG
Rheumatology (Oxford); 2006 Jun; 45(6):649-52. PubMed ID: 16527881
[No Abstract] [Full Text] [Related]
20. [How to deal with suspected rheumatoid arthritis at an early stage].
Gaubitz M
MMW Fortschr Med; 2009 Jul; 151(30-33):47-9. PubMed ID: 19722463
[No Abstract] [Full Text] [Related]
[Next] [New Search]
